GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Net Margin %

SXTC (China SXT Pharmaceuticals) Net Margin % : 667.14% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. China SXT Pharmaceuticals's Net Income for the six months ended in Mar. 2024 was $6.60 Mil. China SXT Pharmaceuticals's Revenue for the six months ended in Mar. 2024 was $0.99 Mil. Therefore, China SXT Pharmaceuticals's net margin for the quarter that ended in Mar. 2024 was 667.14%.

The historical rank and industry rank for China SXT Pharmaceuticals's Net Margin % or its related term are showing as below:

SXTC' s Net Margin % Range Over the Past 10 Years
Min: -300.96   Med: -109.13   Max: 24.27
Current: -160.6


SXTC's Net Margin % is ranked worse than
91% of 989 companies
in the Drug Manufacturers industry
Industry Median: 4.3 vs SXTC: -160.60

China SXT Pharmaceuticals Net Margin % Historical Data

The historical data trend for China SXT Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Net Margin % Chart

China SXT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Margin %
Get a 7-Day Free Trial -199.30 -57.51 -220.45 -300.96 -160.74

China SXT Pharmaceuticals Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -167.87 -123.76 -581.91 -1,031.49 667.14

Competitive Comparison of China SXT Pharmaceuticals's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China SXT Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where China SXT Pharmaceuticals's Net Margin % falls into.



China SXT Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

China SXT Pharmaceuticals's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=-3.099/1.928
=-160.74 %

China SXT Pharmaceuticals's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=6.598/0.989
=667.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China SXT Pharmaceuticals  (NAS:SXTC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


China SXT Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


China SXT Pharmaceuticals Business Description

Traded in Other Exchanges
Address
No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.